WHO ICTRP trial
Exploring the efficacy of dexamethasone combined with tachyzoites in preventing…
ChiCTR2400093821 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400093821 |
|---|---|
| Public title | Exploring the efficacy of dexamethasone combined with tachyzoites in preventing severe postoperative infections after PCNL based on SIRS diagnostic criteria: a multicentre randomised controlled trial |
| Scientific title | Exploring the efficacy of dexamethasone combined with tachyzoites in preventing severe postoperative infections after PCNL based on SIRS diagnostic criteria: a multicentre randomised controlled trial |
| Primary sponsor | Changshu Hospital of Traditional Chinese Medicine (Changshu New District Hospital) |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | kidney stone |
| Interventions | test group:Dexamethasone 10mg, furosemide 10mg at the start of lithotripsy;control group:saline 20mg at the start of lithotripsy |
| Registration date | Dec 12, 2024 |
| Target size | test group:70;control group:70 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: